Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
Tali Cukierman-YaffeUlagamadesan VenkatesanJan BasileM Angelyn BethelErnesto G Cardona-MuñozIgnacio Conget DonloGilles DagenaisEdward FranekStephanie HallNicolae HancuPetr JanskyMark LakshmananFernando Tomás Lanas ZanettiLawrence Alan LeiterPatricio López-JaramilloValdis PiragsNana PogosovaJeffrey L ProbstfieldPurnima Rao-MelaciniChinthanie RamasundarahettigePeter J RaubenheimerMatthew C RiddleLars RydénJonathan E ShawWayne H-H SheuTheodora Temelkova-KurktschievPublished in: The Journal of clinical endocrinology and metabolism (2022)
Country-standardized SCI-GM was a strong independent predictor of cardiovascular events in people with type 2 diabetes in the REWIND trial.